You’re on the right thread. Vaccines will be seasonal and once they take hold the virus will mutate. All RNA viruses mutate quickly.
The virus ability to hijack the AC2 receptor causes vasoconstriction and platelet clotting. Leronlimab would not do much in that sense but it would likely negate ARDS/pneumonia which leads the mortality. Sugar exacerbates the AC2 hijacking making diabetics or anyone with high blood sugar a high risk candidate. Anyone with high blood pressure already is in trouble.
Everyone’s best bet is to have natural antivirals in their blood 24/7 and some Leronlimab in their hospital.
As soon as we figure out CV19 the Birdflu will hit... I.e. we’ll always be chasing. It’s best to address the cytokine storm and reduce mortality.
News 
Market Data 
Discover 
